$0.12
+0.00 (+0.89%)
Open$0.12
Previous Close$0.12
Day High$0.13
Day Low$0.12
52W High$3.16
52W Low$0.48
Volume—
Avg Volume2.0K
Market Cap1.01M
P/E Ratio—
EPS$-2.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,743.4% upside
Current
$0.12
$0.12
Target
$3.54
$3.54
$2.21
$3.54 avg
$4.26
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 186.61M | 159.99M | 4.60M |
| Net Income | -36,558,504 | -28,208,722 | 612.3K |
| Profit Margin | -19.6% | -18.6% | 13.3% |
| EBITDA | -32,558,473 | -26,517,960 | 960.1K |
| Free Cash Flow | — | — | 405.9K |
| Rev Growth | +16.6% | +16.6% | +11.5% |
| Debt/Equity | 3.44 | 3.44 | 0.89 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |